KAMAL MOSTAFA (CEO, Magellan Rx Management) sold 51.6% of their position (6K shares) of MAGELLAN HEALTH INC on the open market
Open‑market sale worth $489.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2020ACC: 0001209191-20-058122
Officer· CEO, Magellan Rx Management
Since Mar 2019
-6K
Net shares
Net seller
$489.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions2
Ordinary Common Stock, $0.01 par value
Direct
Shares
+6K
Price / share
$66.57
Trade value
$399.42K
% of position
106.8%
11/10/2020
5.62K→11.62K
Ordinary Common Stock, $0.01 par value
Direct
Shares
−6K
Price / share
$81.57
Trade value
$489.42K
% of position
51.6%
11/10/2020
11.62K→5.62K
Total
Net shares
+0.00
Net value
-$90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value Direct | 11/10/2020 | X · X | +6K | $66.57 | $399.42K | 106.8% | 5.62K | 11.62K |
| Ordinary Common Stock, $0.01 par value Direct | 11/10/2020 | S · Sale | −6K | $81.57 | $489.42K | 51.6% | 11.62K | 5.62K |
| Total | +0.00 | -$90K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
6K shares
Shares
−6K
Strike price
66.57
Held after
34.81K
Exercisable
—
11/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock6K shares | 11/10/2020 | X · X | −6K | 66.57 | — | 34.81K |